← Leaderboards
Scott A Summers
Colorado State University-Fort Collins
$17,535,017
Attributed
$26,362,437
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,362,437 · 17
By mechanism
R01$14,021,922 · 8
R44$4,709,995 · 1
U01$3,957,452 · 1
T32$2,139,253 · 1
R25$573,910 · 1
R21$482,446 · 1
Top collaborators
- Mary Christine Playdon7 shared
- Cornelia M Ulrich7 shared
- Jeremy Blitzer6 shared
- William L Holland6 shared
- Maija Holsti6 shared
- Bruce A Edgar5 shared
- Amandine H. Chaix1 shared
- Liou Sun1 shared
Others in their field
Top investigators on “Ceramides”
- Yusuf Awni Hannun · Medical University Of South Carolina$31,236,776
- Besim Ogretmen · Medical University Of South Carolina$16,800,540
- Pin-Lan Li · Medical College Of Wisconsin$14,567,134
- Richard N Kolesnick · Sloan-Kettering Inst Can Research$13,993,408
- Susan J Sumner · Research Triangle Institute$13,509,958
- Sarah Spiegel · Virginia Commonwealth University$13,299,666
Research focus
CeramidesMetabolismDiabetes MellitusAnabolismEnzymesMetabolicTissuesCellsRodentObesityPathway InteractionsLipidsBaseLinkDihydroceramide DesaturaseProgramsInsulin ResistanceNon-Insulin-Dependent Diabetes MellitusSphingolipidsGlucoseNovel TherapeuticsFatty AcidsMouse ModelInsulin
Grant awards (68)
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$875,957
U01 · FY2025 · CA
Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals$753,728
R01 · FY2025 · AG
Ceramides in Diastolic Heart Failure$709,508
R01 · FY2025 · HL
The Role of Ceramides in the Pancreatic Beta Cell$550,416
R01 · FY2025 · DK · contact PI
The Role of Ceramides in the Intestinal Stem Cell$512,080
R01 · FY2025 · DK · contact PI
Interdisciplinary Training Program in Metabolism$471,583
T32 · FY2025 · DK · contact PI
Native American Research Internship (NARI) Summer Program in Diabetes, Obesity and Metabolism$108,000
R25 · FY2025 · DK
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$68,468
U01 · FY2025 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2025 · CA
2025 AAIP Academic Career Development Workshop$33,910
R25 · FY2025 · DK
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$907,536
U01 · FY2024 · CA
Ceramides in Diastolic Heart Failure$723,742
R01 · FY2024 · HL
The Role of Ceramides in the Pancreatic Beta Cell$528,401
R01 · FY2024 · DK · contact PI
The Role of Ceramides in the Intestinal Stem Cell$491,596
R01 · FY2024 · DK · contact PI
Interdisciplinary Training Program in Metabolism$368,737
T32 · FY2024 · DK · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$145,862
U01 · FY2024 · CA · contact PI
Native American Research Internship (NARI) Summer Program in Diabetes, Obesity and Metabolism$108,000
R25 · FY2024 · DK
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$47,420
U01 · FY2024 · CA
Interdisciplinary Training Program in Metabolism$45,596
T32 · FY2024 · DK · contact PI
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$950,923
U01 · FY2023 · CA
The Role of Ceramides in the Pancreatic Beta Cell$550,023
R01 · FY2023 · DK · contact PI
The Role of Ceramides in the Intestinal Stem Cell$512,080
R01 · FY2023 · DK · contact PI
Interdisciplinary Training Program in Metabolism$353,962
T32 · FY2023 · DK · contact PI
Native American Research Internship (NARI) Summer Program in Diabetes, Obesity and Metabolism$108,000
R25 · FY2023 · DK
Interdisciplinary Training Program in Metabolism$43,714
T32 · FY2023 · DK · contact PI
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$1,069,999
R44 · FY2022 · DK
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer$913,866
U01 · FY2022 · CA
The Role of Ceramides in the Pancreatic Beta Cell$562,220
R01 · FY2022 · DK · contact PI
The Role of Ceramides in the Intestinal Stem Cell$512,080
R01 · FY2022 · DK · contact PI
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders$465,796
R01 · FY2022 · DK · contact PI
Interdisciplinary Training Program in Metabolism$439,877
T32 · FY2022 · DK · contact PI
Native American Research Internship (NARI) Summer Program in Diabetes, Obesity and Metabolism$108,000
R25 · FY2022 · DK
Interdisciplinary Training Program in Metabolism$42,696
T32 · FY2022 · DK · contact PI
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$1,069,999
R44 · FY2021 · DK
The Role of Ceramides in Skeletal Muscle$645,781
R01 · FY2021 · DK · contact PI
The Role of Ceramides in the Intestinal Stem Cell$512,080
R01 · FY2021 · DK · contact PI
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders$465,796
R01 · FY2021 · DK · contact PI
Interdisciplinary Training Program in Metabolism$373,088
T32 · FY2021 · DK · contact PI
Native American Research Internship (NARI) Summer Program in Diabetes, Obesity and Metabolism$108,000
R25 · FY2021 · DK
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$1,069,999
R44 · FY2020 · DK
The Role of Ceramides in Skeletal Muscle$645,781
R01 · FY2020 · DK · contact PI
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders$465,796
R01 · FY2020 · DK · contact PI
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$749,999
R44 · FY2019 · DK
The Role of Ceramides in Skeletal Muscle$645,781
R01 · FY2019 · DK · contact PI
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders$478,921
R01 · FY2019 · DK · contact PI
The Role of Ceramides in Skeletal Muscle$43,934
R01 · FY2019 · DK · contact PI
FASEB SRC on Regulation of Glucose Metabolism: From Cell Biology to Systems Physiology$14,668
R13 · FY2019 · DK · contact PI
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$749,999
R44 · FY2018 · DK
The Role of Ceramides in Skeletal Muscle$643,664
R01 · FY2018 · DK · contact PI
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases$225,000
R43 · FY2017 · DK
Lipid Mediators of Insulin Resistance$324,903
R01 · FY2012 · DK · contact PI
Lipid Mediators of Insulin Resistance$324,903
R01 · FY2011 · DK · contact PI
Lipid Mediators of Insulin Resistance$328,185
R01 · FY2010 · DK · contact PI
Lipid Mediators of Insulin Resistance$331,500
R01 · FY2009 · DK · contact PI
Lipid Mediators of Insulin Resistance$229,565
R01 · FY2008 · DK · contact PI
Role of Ceramide in Hepatic Insulin Resistance$187,708
R56 · FY2008 · DK · contact PI
Lipid Mediators of Insulin Resistance$99,813
R01 · FY2008 · DK · contact PI
The role of sphingolipids in the pancreatic beta cell$245,151
R21 · FY2007 · DK · contact PI
The role of sphingolipids in the pancreatic beta cell$13,045
R21 · FY2007 · DK · contact PI
The role of sphingolipids in the pancreatic beta cell$224,250
R21 · FY2006 · DK · contact PI
The role of sphingolipids in insulin signal transduction$50,083
R56 · FY2006 · DK · contact PI
The role of sphingolipids in insulin signal transduction$128,599
R01 · FY2004 · DK
The role of sphingolipids in insulin signal transduction$97,821
R01 · FY2004 · DK
The role of sphingolipids in insulin signal transduction$39,027
R01 · FY2004 · DK
The role of sphingolipids in insulin signal transduction$22,233
R01 · FY2004 · DK
The role of sphingolipids in insulin signal transduction$217,052
R01 · FY2003 · DK
The role of sphingolipids in insulin signal transduction$216,980
R01 · FY2002 · DK
The role of sphingolipids in insulin signal transduction$242,137
R01 · FY2001 · DK